Dysequilibrium syndrome: Difference between revisions
| Line 25: | Line 25: | ||
*Supratheurapeutic Medication Effects | *Supratheurapeutic Medication Effects | ||
*PRES | *PRES | ||
==Evaluation== | |||
*Clinical Diagonosis | |||
*Bedside Glucose | |||
*CBC | |||
*Chem-10 | |||
*Liver Panel | |||
*CT Brain | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Revision as of 01:44, 14 April 2017
Background
- Characterized by neurological symptoms that is thought to be secondary to cerebral edema affecting dialysis patients
- Tends to occur in patients who are initially started on dialysis, particularly with high initial BUN
- Symptoms are thought to be secondary to the development of cerebral edema possibly due to urea removal during dialysis and from a decreased in pH in the cerebral intracelluar environment
Clinical Features
- Signs and symptoms develop during or after dialysis or during renal replacement therapy, usually self limited but can occasionally progress
- Headache
- Nausea
- Visual disturbances
- Asterixis
- Altered mental staus
- Seizures
- Coma
- Muscle Cramps
Differential Diagonsis
- Hypoglycemia
- Hyponatremia
- Hypocalcemia
- Uremia
- Intracranial Bleed
- Hypertensive Emergency
- Stroke
- Supratheurapeutic Medication Effects
- PRES
Evaluation
- Clinical Diagonosis
- Bedside Glucose
- CBC
- Chem-10
- Liver Panel
- CT Brain